scholarly article | Q13442814 |
P356 | DOI | 10.1002/JMV.10182 |
P698 | PubMed publication ID | 12210408 |
P2093 | author name string | Gary P Jeffrey | |
W Bastiaan de Boer | |||
Kieran A McCaul | |||
Jane E Allan | |||
Michael A Platten | |||
Gerry C MacQuillan | |||
William D Reed | |||
P2860 | cites work | Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group | Q42984083 |
Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway | Q43030367 | ||
Antibodies developing against a single recombinant interferon protein may neutralize many other interferon-alpha subtypes. | Q43038858 | ||
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I | Q45752944 | ||
Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promoter and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes. | Q45949957 | ||
Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 | ||
Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization | Q24529053 | ||
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation | Q27469500 | ||
Histological grading and staging of chronic hepatitis | Q29619625 | ||
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team | Q29619749 | ||
Molecular and functional analysis of the virus- and interferon-inducible human MxA promoter | Q33261592 | ||
Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity | Q33931051 | ||
Mechanism of interferon action: autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells | Q37299425 | ||
MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon | Q40703041 | ||
Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner | Q40801087 | ||
Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy | Q40816503 | ||
Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response | Q40921231 | ||
The double-stranded RNA-dependent protein kinase PKR: structure and function | Q41614652 | ||
Mx genes show weaker primary response to virus than other interferon-regulated genes | Q41649414 | ||
In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus | Q42474311 | ||
P433 | issue | 2 | |
P921 | main subject | Hepatitis C virus | Q708693 |
chronic hepatitis C | Q55779873 | ||
chronic hepatitis | Q62019625 | ||
P304 | page(s) | 197-205 | |
P577 | publication date | 2002-10-01 | |
P1433 | published in | Journal of Medical Virology | Q15716684 |
P1476 | title | Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection | |
P478 | volume | 68 |
Q84130039 | Cell-type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chronic HBV infected patients |
Q21245110 | Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha |
Q57632335 | Expression of biomarkers of interferon type I in patients suffering from chronic diseases |
Q38435429 | Expression of toll-like receptors and type 1 interferon specific protein MxA in biliary atresia |
Q27490906 | Genomic scale analysis of racial impact on response to IFN-alpha |
Q35136312 | Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection |
Q34190570 | Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes |
Q36749431 | Hepatitis C virus infection--pathobiology and implications for new therapeutic options |
Q42995363 | Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines |
Q42990438 | Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation |
Q35675878 | IFN-λ: A New Class of Interferon with Distinct Functions-Implications for Hepatitis C Virus Research |
Q36367633 | Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis |
Q44286199 | Interferon-stimulated gene expression in black and white hepatitis C patients during peginterferon alfa-2a combination therapy |
Q50569910 | Intrahepatic interferon-stimulated gene responses: can they predict treatment responses in chronic hepatitis C infection? |
Q40179377 | MxA Is A Positive Regulator of Type I IFN Signaling in HCV Infection. |
Q29620681 | Novel insights into hepatitis C virus replication and persistence |
Q39702101 | Preparation of polyclonal antibody against human MxA protein and its specificity to diversified myxovirus resistant protein A. |
Q34082923 | Ribavirin enhances IFN-α signalling and MxA expression: a novel immune modulation mechanism during treatment of HCV. |
Q45382415 | Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus disease |
Q43048844 | Upregulation of endogenous intrahepatic interferon stimulated genes during chronic hepatitis C virus infection |
Search more.